NasdaqGS:MEDPLife Sciences
Is Medpace Holdings (MEDP) Still Appealing After Recent Volatility And Zelluna Partnership Expectations
If you are trying to figure out whether Medpace Holdings at around US$450 per share is still good value, you are not alone. This article is written with that question front and center.
The stock has had a mixed run recently, with a 4.3% decline over the last 7 days, a 5.2% gain over 30 days, a 21.1% decline year to date, yet a 38.6% return over 1 year and a 156.4% return over 3 years.
These moves have kept Medpace on many investors' watchlists, with attention on how its contract research...